EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer

Chie Masaki iD, Norihito Inoue iD, Tomohiro Chiba iD

Cells · 12.05.2026 · 15 (10) · 884

DOI: 10.3390/cells15100884 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 12.05.2026. Verfasst von Chie Masaki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Signal Transduction, STAT3 Transcription Factor, STAT Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Signal transducers and activators of transcription (STAT) proteins, which operate via canonical and non-canonical mechanisms, are critically implicated in thyroid tumorigenesis. This review integrates their multifaceted roles in thyroid cancer. STAT3 acts as a “double-edged sword”: hyperactive STAT3 drives metastasis and BRAF inhibitor resistance in advanced carcinomas, yet paradoxically acts as a tumor suppressor by restraining the Warburg effect via non-canonical mitochondrial localization. Clinically, preserved nuclear STAT3 independently predicts a favorable prognosis and is inversely correlated with TERT promoter mutations, offering a biological modifier for clinical risk stratification. Furthermore, STAT1 regulates differentiation via the IGF2BP2-m6A axis, STAT5 drives proliferation upon release from TRβ suppression, and STAT6 confers chemoresistance. While novel direct STAT3 inhibitors (e.g., TTI-101) and rational combinations with immune checkpoint inhibitors or STING agonists show promise in overcoming refractory disease, the intricate dual functionality of STAT family proteins demands rigorous biomarker-guided precision medicine approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsSignal TransductionSTAT3 Transcription FactorSTAT Transcription FactorsHumansAnimals

Stichwörter der Autor:innen

BRAF inhibitorJAK-STAT pathwaySTAT3double-edged sworddrug resistancetargeted therapythyroid cancertumor microenvironment

Substanzen

STAT3 Transcription FactorSTAT Transcription FactorsSTAT3 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.
  • Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan.
  • Department of Cytology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

ORCID-Profile: Chie Masaki, Norihito Inoue, Tomohiro Chiba

Förderung

  • Japan Society for the Promotion of Science
  • Japan Society for the Promotion of Science KAKENHI

Zitieren

APA

Masaki, C., Inoue, N., & Chiba, T. (2026). Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer. Cells, 15(10), 884. https://doi.org/10.3390/cells15100884

Vancouver

Masaki C, Inoue N, Chiba T. Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer. Cells. 2026;15(10):884. doi:10.3390/cells15100884

BibTeX
@article{Masaki2026,
  author = {Masaki, Chie and Inoue, Norihito and Chiba, Tomohiro},
  title = {Roles of STAT3 and STAT Family Proteins and Their Signaling Pathways in Thyroid Cancer},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {884},
  doi = {10.3390/cells15100884}
}
Kostenlos starten →